Scinovex
article Open AccessTop 1% cited

Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups

American Journal of Transplantation · 2010 · Vol. 10(3) · pp. 464–471
B. SisMichael MengelMark HaasRobert B. ColvinPhilip F. HalloranLorraine C. RacusenKim SolezWilliam M. BaldwinErika BracamonteVerena BroeckerBorja G. CosíoA J DemetrisCinthia B. DrachenbergGunilla EineckeJ.M. GloorDenis GlotzEdward S. KrausClaire LegendreHelen LiapisRoslyn B. MannonBrian J. NankivellVolker NickeleitJohn C. PapadimitriouParmjeet RandhawaHeinz RegeleKarine RenaudinE. René RodríguezDaniel SerónSurya V. SeshanManikkam SuthanthiranB Wa̧sowskaAndrea A. ZacharyAdriana Zeevi

Abstract

The 10th Banff Conference on Allograft Pathology was held in Banff, Canada from August 9 to 14, 2009. A total of 263 transplant clinicians, pathologists, surgeons, immunologists and researchers discussed several aspects of solid organ transplants with a special focus on antibody mediated graft injury. The willingness of the Banff process to adapt continuously in response to new research and improve potential weaknesses, led to the implementation of six working groups on the following areas: isolated v-lesion, fibrosis scoring, glomerular lesions, molecular pathology, polyomavirus nephropathy and quality assurance. Banff working groups will conduct multicenter trials to evaluate the clinical relevance, practical feasibility and reproducibility of potential changes to the Banff classification. There were also sessions on quality improvement in biopsy reading and utilization of virtual microscopy for maintaining competence in transplant biopsy interpretation. In addition, compelling molecular research data led to the discussion of incorporation of omics-technologies and discovery of new tissue markers with the goal of combining histopathology and molecular parameters within the Banff working classification in the near future.

MeSH terms

AntibodiesBiopsyCanadaFibrosisHumansKidney DiseasesPeptide FragmentsPhenotypeQuality ControlMulticenter Studies as TopicComplement C4bKidney TransplantationOrgan TransplantationPolyomavirus Infections

Funding

  • Bristol-Myers Squibb
  • Renal Pathology Society
  • University of Alberta
  • Astellas Pharma
Citations
758
FWCI
47.41
field-weighted impact
References
49
Percentile
100%
vs. same field & year
Citations per year
References
The Banff 97 working classification of renal allograft pathology
Kidney International · 1999 · 3,045 citations
Identifying Specific Causes of Kidney Allograft Loss
American Journal of Transplantation · 2009 · 784 citations
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
American Journal of Transplantation · 2008 · 1,853 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.